Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K040888
    Date Cleared
    2004-12-01

    (240 days)

    Product Code
    Regulation Number
    882.5910
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K950956, K982180

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    DuraMatrix™ Collagen Dura Substitute Membrane is indicated for use as a dural substitute for the repair of dura mater.

    Device Description

    The Collagen Dura Substitute Membrane is a white, nonfriable, conformable, resorbable, membrane matrix engineered from highly purified type I collagen derived from bovine Achilles tendon. The device has a thickness similar to that of native dura. It is flexible and conforms to the contours of the defect site. The unique conformability properties of the membrane combined with its mechanical strength allow the membrane matrix to be applied as an onlay membrane or sutured in place. The Collagen Dura Substitute Membrane is supplied sterile, non-pyrogenic, in various sizes, and for single use only.

    AI/ML Overview

    This 510(k) summary describes a medical device, the DuraMatrix™ Collagen Dura Substitute Membrane, which is not an AI or software device. Therefore, many of the requested categories in the prompt, such as "multi reader multi case (MRMC) comparative effectiveness study," "standalone (i.e. algorithm only without human-in-the loop performance)," "sample size for the training set," and "how the ground truth for the training set was established" are not applicable.

    Here's an analysis of the provided text based on the other relevant categories for this type of device:

    Acceptance Criteria and Device Performance Study for DuraMatrix™ Collagen Dura Substitute Membrane

    1. Table of Acceptance Criteria and Reported Device Performance

    The provided text for K040888 focuses on demonstrating substantial equivalence to predicate devices rather than specific quantitative performance metrics against pre-defined acceptance criteria for a novel AI or software device. The acceptance is based on the device meeting design requirements for an effective dura substitute and passing various safety and biocompatibility tests.

    CategoryAcceptance Criteria (Implied/General)Reported Device Performance
    SafetyCompliance with FDA Blue Book Memorandum G95-1 and ISO 10993-1 for biological evaluation of medical devices."The device passed all applicable FDA Blue Book Memorandum G95-1 and ISO 10993-1 testing for the biological evaluation of medical devices." This implies meeting the acceptance criteria for each test within these guidelines. Specific numerical thresholds or results are not provided in this summary.
    Effectiveness (Dura Substitute)Must meet design requirements for an effective dura substitute."The results of a large-scale animal study and clinical study support the effectiveness of using a membrane material as a dura substitute in the repair of dura mater. The characteristics of the Collagen Dura Substitute Membrane meet the design requirements for an effective dura substitute." Specific details of these study results are not provided in this summary.
    Technological Characteristics (Comparison)Similar to predicate devices (Dura-Guard® Dural Repair Patch, DuraGen® Dural Graft Matrix) in key characteristics."Collagen Dura Substitute Membrane and its predicates have similar technological characteristics. In particular, the Collagen Dura Substitute Membrane and its predicates are similar with respect to intended use, material, form, sizes, thickness, physical integrity, porosity and conformability." This indicates the device met the criteria of being sufficiently similar to the legally marketed predicates.

    2. Sample Size Used for the Test Set and Data Provenance

    The summary mentions a "large-scale animal study and clinical study" but does not provide specific sample sizes for either.
    The data provenance (country of origin, retrospective/prospective) is not specified.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not applicable for this type of device. The "ground truth" for a dura substitute is assessed through its physiological performance and safety in animal models and clinical use.

    4. Adjudication Method for the Test Set

    Not applicable for this type of device.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable, as this is a medical implant, not an AI or software device.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    Not applicable, as this is a medical implant, not an AI or software device.

    7. The Type of Ground Truth Used

    For the safety and effectiveness of a dura substitute, the "ground truth" would be established through:

    • Biocompatibility testing: In vitro and in vivo tests (e.g., cytotoxicity, sensitization, irritation, genotoxicity, implantation studies) according to ISO 10993-1 and FDA G95-1 guidelines. The "ground truth" for these tests are the established biological responses that indicate safety.
    • Animal study outcomes: Histological analysis of tissue response, assessment of dural repair integrity, absence of adverse events like CSF leakage or infection.
    • Clinical study outcomes: Patient outcomes related to dural repair, absence of complications, healing, and functionality.

    8. The Sample Size for the Training Set

    Not applicable, as this is a medical implant, not an AI or software device that uses a training set in the computational sense. The "training" in this context would refer to the extensive R&D, material characterization, and iterative design work that precedes formal testing.

    9. How the Ground Truth for the Training Set was Established

    Not applicable, as this is a medical implant, not an AI or software device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K032693
    Date Cleared
    2003-09-30

    (28 days)

    Product Code
    Regulation Number
    882.5910
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K982180

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    DuraGen Plus™ Dural Graft Matrix is indicated as a dura substitute for the repair of dura mater.

    Device Description

    DuraGen Plus™ Dural Graft Matrix, is an absorbable implant for repair of dural defects. DuraGen Plus™ is an easy to handle, soft, white, pliable, nonfriable, porous collagen matrix. DuraGen Plus™ is supplied sterile, nonpyrogenic, for single use in double peel packages in a variety of sizes.

    AI/ML Overview

    The provided text, a 510(k) summary for DuraGen Plus™ Dural Graft Matrix, does not contain the detailed information required to fill out the requested table and answer all questions regarding acceptance criteria and a study proving device performance in the context of an AI/human reader study.

    This document describes a medical device, DuraGen Plus™ Dural Graft Matrix, and seeks substantial equivalence to a predicate device. The assessment of this type of device typically involves physical property testing and not clinical trials or AI/human reader studies as would be the case for diagnostic or image-based AI software.

    Here's how I can answer based only on the provided text, highlighting what's missing:


    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not explicitly state acceptance criteria in a quantitative or qualitative manner that would be filled in a table, nor does it provide specific performance metrics from a study related to those criteria. It broadly states the device is "safe and effective under the proposed conditions of use."

    Acceptance CriteriaReported Device Performance
    Not specified in document"Valid scientific evidence through physical property testing provide reasonable assurance that DuraGen Plus™ Dural Graft Matrix is safe and effective under the proposed conditions of use..."

    2. Sample size used for the test set and the data provenance

    Not applicable. The clearance is based on physical property testing, not a test set of data from patients or images.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. Ground truth for a test set is not relevant for this type of device clearance.

    4. Adjudication method for the test set

    Not applicable.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    No. This is a medical device (dural graft matrix), not an AI software/diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    No. This is a medical device, not an algorithm.

    7. The type of ground truth used

    Not applicable in the context of clinical outcomes or diagnostic accuracy. The "ground truth" for a dural graft matrix would relate to its physical and biological properties. The document mentions "physical property testing."

    8. The sample size for the training set

    Not applicable. There is no "training set" for this type of device.

    9. How the ground truth for the training set was established

    Not applicable.


    Summary of what the document does communicate about the study:

    • Study Type: The clearance is based on "Valid scientific evidence through physical property testing." This implies laboratory or bench-top testing of the material properties of the DuraGen Plus™ Dural Graft Matrix.
    • Conclusion of Study: The testing provided "reasonable assurance that DuraGen Plus™ Dural Graft Matrix is safe and effective under the proposed conditions of use, and is, with respect to intended use and technological characteristics, substantially equivalent to the predicate device [DuraGen® Dural Graft Matrix (K982180)]."
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1